Loading...
Market
Which country will approve the new cervical cancer treatment first by end of 2025?
2
Resolution / Starting Odds
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
Official health department announcements from respective countries
Story
Lancet Study: New Cervical Cancer Treatment Cuts Death Risk by 40%, Major Breakthrough in 20 Years
Oct 15, 2024, 09:24 AM
A new cervical cancer treatment regime has been identified as a significant advancement in medical care, reportedly reducing the risk of death from the disease by 40%. This breakthrough, described as the most substantial improvement in cervical cancer treatment in two decades, involves a change in the order of drug administration. Researchers highlighted that this simple adjustment has transformed survival rates for patients. The findings were published in a study by The Lancet, marking a pivotal moment in the ongoing fight against cervical cancer.
View original story
Similar markets
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
0-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
More than 15 countries • 25%
Less than 20 countries • 25%
20 to 40 countries • 25%
41 to 60 countries • 25%
More than 60 countries • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
China • 25%
India • 25%
Brazil • 25%
Other • 25%
Europe • 25%
United States • 25%
Asia • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
USA • 25%
UK • 25%
South Africa • 25%
Other • 25%
United States • 25%
European Union • 25%
South Africa • 25%
Other • 25%
UK • 14%
USA • 14%
Germany • 14%
France • 14%
Japan • 14%
Australia • 14%
Other • 14%